Résultats de recherche
Le BDAE est un test qui évalue les troubles de la langue et du traitement après un AVC. Il comprend des sections sur la fluidité, la compréhension auditive, la production auditive, la lecture, l'écriture et la manipulation.
Le Boston Diagnostic Aphasia Examination (BDAE) est un test neuropsychologique évaluant le langage. Mis au point en 1972 par Goodglass et Kaplan 1, il est le plus utilisé au monde. Il a en effet été traduit et étalonné pour les hispanophones 2, les lusophones 3 et les grécophones 4 .
The BDAE is a comprehensive test to diagnose aphasia and related disorders after stroke. It evaluates various modalities and functions, such as fluency, comprehension, naming, repetition, and writing.
The Boston Diagnostic Aphasia Examination is a neuropsychological battery used to evaluate adults suspected of having aphasia, and is currently in its third edition. [1] It was created by Harold Goodglass and Edith Kaplan.
Items extraits du “Boston Diagnostic Aphasia Examination (BDAE)” Score de 0 à 5 évalué après les épreuves de conversation (A) et de langage spontané (B)
Learn about the BDAE, a test for assessing aphasia subtypes and severity, and its relation to other batteries such as the WAB. Find chapters and articles on the BDAE and related topics from ScienceDirect.
BDAE-3 is a paper and pencil test that evaluates aphasia and related disorders in adults. It includes the Boston Naming Test, the Extended Standard Form, the Short Form, and other tools for diagnosis and analysis.
